15 results on '"van den Bongard, Desirée H. J. G."'
Search Results
2. Health-related quality of life of early-stage breast cancer patients after different radiotherapy regimens
- Author
-
Jacobs, Daphne H. M., Charaghvandi, Ramona K., Horeweg, Nanda, Maduro, John H., Speijer, Gabrielle, Roeloffzen, Ellen M. A., Mast, Mirjam, Bantema-Joppe, Enja, Petoukhova, Anna L., van den Bongard, Desirée H. J. G., Koper, Peter, Crijns, Anne P. G., Marijnen, Corrie A. M., and Verkooijen, Helena M.
- Published
- 2021
- Full Text
- View/download PDF
3. Identification of Risk of Cardiovascular Disease by Automatic Quantification of Coronary Artery Calcifications on Radiotherapy Planning CT Scans in Patients With Breast Cancer
- Author
-
Gal, Roxanne, primary, van Velzen, Sanne G. M., additional, Hooning, Maartje J., additional, Emaus, Marleen J., additional, van der Leij, Femke, additional, Gregorowitsch, Madelijn L., additional, Blezer, Erwin L. A., additional, Gernaat, Sofie A. M., additional, Lessmann, Nikolas, additional, Sattler, Margriet G. A., additional, Leiner, Tim, additional, de Jong, Pim A., additional, Teske, Arco J., additional, Verloop, Janneke, additional, Penninkhof, Joan J., additional, Vaartjes, Ilonca, additional, Meijer, Hanneke, additional, van Tol-Geerdink, Julia J., additional, Pignol, Jean-Philippe, additional, van den Bongard, Desirée H. J. G., additional, Išgum, Ivana, additional, and Verkooijen, Helena M., additional
- Published
- 2021
- Full Text
- View/download PDF
4. Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
- Author
-
Eijkelboom, Anouk H., de Munck, Linda, Vrancken Peeters, Marie-Jeanne T. F. D., Broeders, Mireille J. M., Strobbe, Luc J. A., Bos, Monique E. M. M., Schmidt, Marjanka K., Guerrero Paez, Cristina, Smidt, Marjolein L., Bessems, Maud, Verloop, Janneke, Linn, Sabine, Lobbes, Marc B. I., Honkoop, Aafke H., van den Bongard, Desirée H. J. G., Westenend, Pieter J., Wesseling, Jelle, Menke-van der Houven van Oordt, C. Willemien, Tjan-Heijnen, Vivianne C. G., and Siesling, Sabine
- Subjects
COVID-19 pandemic ,COVID-19 testing ,BREAST cancer ,MEDICAL care ,CANCER treatment - Abstract
Background: The onset of the COVID-19 pandemic forced the Dutch national screening program to a halt and increased the burden on health care services, necessitating the introduction of specific breast cancer treatment recommendations from week 12 of 2020. We aimed to investigate the impact of COVID-19 on the diagnosis, stage and initial treatment of breast cancer. Methods: Women included in the Netherlands Cancer Registry and diagnosed during four periods in weeks 2–17 of 2020 were compared with reference data from 2018/2019 (averaged). Weekly incidence was calculated by age group and tumor stage. The number of women receiving initial treatment within 3 months of diagnosis was calculated by period, initial treatment, age, and stage. Initial treatment, stratified by tumor behavior (ductal carcinoma in situ [DCIS] or invasive), was analyzed by logistic regression and adjusted for age, socioeconomic status, stage, subtype, and region. Factors influencing time to treatment were analyzed by Cox regression. Results: Incidence declined across all age groups and tumor stages (except stage IV) from 2018/2019 to 2020, particularly for DCIS and stage I disease (p < 0.05). DCIS was less likely to be treated within 3 months (odds ratio [OR]
wks2–8 : 2.04, ORwks9–11 : 2.18). Invasive tumors were less likely to be treated initially by mastectomy with immediate reconstruction (ORwks12–13 : 0.52) or by breast conserving surgery (ORwks14–17 : 0.75). Chemotherapy was less likely for tumors diagnosed in the beginning of the study period (ORwks9–11 : 0.59, ORwks12–13 : 0.66), but more likely for those diagnosed at the end (ORwks14–17 : 1.31). Primary hormonal treatment was more common (ORwks2–8 : 1.23, ORwks9–11 : 1.92, ORwks12–13 : 3.01). Only women diagnosed in weeks 2–8 of 2020 experienced treatment delays. Conclusion: The incidence of breast cancer fell in early 2020, and treatment approaches adapted rapidly. Clarification is needed on how this has affected stage migration and outcomes. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
5. Trends in the risk of cardiovascular disease in women with breast cancer in a Dutch nationwide cohort study
- Author
-
Buddeke, Josefien, primary, Gernaat, Sofie A M, additional, Bots, Michiel L, additional, van den Bongard, Desirée H J G, additional, Grobbee, Diederick E, additional, Vaartjes, Ilonca, additional, and Verkooijen, Helena M, additional
- Published
- 2019
- Full Text
- View/download PDF
6. Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability?
- Author
-
HARTOGH, MARISKA D. DEN, PHILIPPENS, MARIELLE E. P., VAN DAM, IRIS E., KLEYNEN, CATHARINA E., TERSTEEG, ROBBERT J.H.A., KOTTE, ALEXIS N. T. J., VAN VULPEN, MARCO, VAN ASSELEN, BRAM, and VAN DEN BONGARD, DESIRÉE H. J. G.
- Subjects
LUMPECTOMY ,LARGE-breasted women ,MAMMOGRAMS ,IRRADIATED foods ,FOOD irradiation - Abstract
For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is reduced by providing the radiation oncologist with additional magnetic resonance imaging (MRI) or CT scans. A total of 14 T1-T2 breast cancer patients underwent a standard planning CT in the supine treatment position following lumpectomy, as well as additional pre- and postoperative imaging in the same position. Post-lumpectomy TBs were independently delineated by four breast radiation oncologists on standard postoperative CT and on CT registered to an additional imaging modality. The additional imaging modalities used were postoperative MRI, preoperative contrast-enhanced (CE)-CT and preoperative CE-MRI. A cavity visualization score (CVS) was assigned to each standard postoperative CT by each observer. In addition, the conformity index (CI), volume and distance between centers of mass (dCOM) of the TB delineations were calculated. On CT, the median CI was 0.57, with a median volume of 22 cm3 and dCOM of 5.1 mm. The addition of postoperative MRI increased the median TB volume significantly to 28 cm3 (P<0.001), while the CI (P=0.176) and dCOM (P=0.110) were not affected. The addition of preoperative CT or MRI increased the TB volume to 26 and 25 cm3, respectively (both P<0.001), while the CI increased to 0.58 and 0.59 (both P<0.001) and the dCOM decreased to 4.7 mm (P=0.004) and 4.6 mm (P=0.001), respectively. In patients with CVS=3, the median CI was 0.40 on CT, which was significantly increased by all additional imaging modalities, up to 0.52, and was accompanied by a median volume increase up to 6 cm3. In conclusion, the addition of postoperative MRI, preoperative CE-CT or preoperative CE-MRI did not result in a considerable reduction in the IOV in postoperative CT-guided TB delineation, while target volumes marginally increased. The value of additional imaging may be dependent on CVS. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
7. Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands.
- Author
-
Eijkelboom AH, Stam MR, van den Bongard DHJG, Sattler MGA, Bantema-Joppe EJ, Siesling S, and van Maaren MC
- Abstract
Background and Purpose: The COVID-19 pandemic resulted in an accelerated recommendation to use five-fraction radiotherapy schedules, according to the FAST- and FAST-Forward trial. In this study, trends in the use of different radiotherapy schedules in the Netherlands were studied, as well as the likelihood of receiving five fractions., Materials and Methods: Data from the NABON Breast Cancer Audit-Radiotherapy and Netherlands Cancer Registry was used. Women receiving radiotherapy for their primary invasive breast cancer or DCIS between 01-01-2020 and 31-12-2021 were included. Logistic regression was used to investigate the association between patient-, tumour-, treatment-, and radiotherapy institution-related characteristics and the likelihood of receiving five fractions in tumours meeting the FAST and FAST-Forward criteria., Results: Detailed information about radiotherapy treatment was available for 9,392 tumours. Shortly after the start of the COVID-19 pandemic, i.e. April 2020, 19% of the tumours being treated with radiotherapy received five fractions of 5.2 or 5.7 Gray (Gy). While only 3% of the tumours received five fractions in March 2020. The usage of five fractions increased to 26% in December 2021. Partial breast irradiation, compared to whole breast irradiation, was significantly associated with the administration of five fractions, as well as radiotherapy delivered in an academic radiotherapy institution compared to an independent institution., Conclusion: The start of the COVID-19 pandemic was associated with the early use of ultra-hypofractionated radiotherapy schedules. After publication of the trials, and mainly after the recommendation by the national radiotherapy society, the implementation further increased. These schedules were not yet used in all patients meeting the eligibility criteria for the FAST- or FAST-Forward trial., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF
8. The use of a wearable cardioverter defibrillator during postmastectomy radiotherapy as an alternative for relocation of the pulse generator.
- Author
-
Koken PW, van den Bongard DHJG, and Kooiman KM
- Abstract
Purpose: We describe a case in which a breast cancer patient with an implantable cardioverter-defibrillator (ICD) was treated with postmastectomy followed by axillary radiation therapy. The ICD was partly within the target volume and according to the treatment planning system would receive a maximum dose of about 36 Gy., Methods and Materials: Postoperatively, the patient had a wound infection needing surgical intervention and 3 months of antibiotics. Therefore, it was decided not to relocate the ICD but instead to switch off the shock function of the ICD for the entire radiation therapy course., Results: The ICD was successfully substituted with a wearable cardioverter defibrillator (WCD), which the patient wore during the 3-week radiation therapy period until 2 weeks after the end of treatment. The ICD function was monitored from the start of the treatment until 6 months after treatment., Conclusions: In situations in which an ICD needs to be switched off semipermanently, a WCD can be used as alternative. The patient in this report tolerated the WCD well. Despite the high dose received by the ICD, the device and its battery continued to function normally., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
9. AI-Based Radiation Dose Quantification for Estimation of Heart Disease Risk in Breast Cancer Survivors After Radiation Therapy.
- Author
-
van Velzen SGM, Gal R, Teske AJ, van der Leij F, van den Bongard DHJG, Viergever MA, Verkooijen HM, and Išgum I
- Subjects
- Artificial Intelligence, Female, Humans, Radiation Dosage, Risk Factors, Breast Neoplasms complications, Breast Neoplasms diagnostic imaging, Breast Neoplasms radiotherapy, Cancer Survivors, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease etiology, Heart Diseases diagnostic imaging, Heart Diseases etiology
- Abstract
Purpose: To investigate whether the dose planned for cardiac structures is associated with the risk of heart disease (HD) in patients with breast cancer treated with radiation therapy, and whether this association is modified by the presence of coronary artery calcification (CAC)., Methods and Materials: Radiation therapy planning computed tomographic (CT) scans and corresponding dose distribution maps of 5561 patients were collected, 5300 patients remained after the exclusion of ineligible patients and duplicates; 1899 patients received their CT scan before 2011, allowing long follow-up. CAC was detected automatically. Using an artificial intelligence-based method, the cardiac structures (heart, cardiac chambers, large arteries, 3 main coronary arteries) were segmented. The planned radiation dose to each structure separately and to the whole heart were determined. Patients were assigned to a low-, medium-, or high-dose group based on the dose to the respective heart structure. Information on HD hospitalization and mortality was obtained for each patient. The association of planned radiation dose to cardiac structures with risk of HD was investigated in patients with and without CAC using Cox proportional hazard analysis in the long follow-up population. Tests for interaction were performed., Results: After a median follow-up of 96.0 months (interquartile range, 84.2-110.4 months) in the long follow-up group, 135 patients were hospitalized for HD or died of HD. If the dose to a structure increased 1 Gy, the relative HD risk increased by 3% to 11%. The absolute increase in HD risk was substantially higher in patients with CAC (event-rate
low-dose = 14-15 vs event-ratehigh-dose = 15-34 per 1000 person-years) than in patients without CAC (event-ratelow-dose = 6-8 vs event-ratehigh-dose = 5-17 per 1000 person-years). No interaction between CAC and radiation dose was found., Conclusions: Radiation exposure of cardiac structures is associated with increased risk of HD. Automatic segmentation of cardiac structures enables spatially localized dose estimation, which can aid in the prevention of radiation therapy-induced cardiac damage. This could be especially valuable in patients with breast cancer and CAC., (Copyright © 2021 Elsevier Inc. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF
10. Compression Vest Treatment for Symptomatic Breast Edema in Women Treated for Breast Cancer: A Pilot Study.
- Author
-
Gregorowitsch ML, Van den Bongard DHJG, Batenburg MCT, Traa-van de Grootevheen MJC, Fuhler N, van Het Westeinde T, van der Pol CC, Young-Afat DA, and Verkooijen HM
- Subjects
- Breast Cancer Lymphedema etiology, Breast Cancer Lymphedema pathology, Breast Cancer Lymphedema psychology, Breast Neoplasms complications, Breast Neoplasms pathology, Breast Neoplasms surgery, Edema etiology, Edema pathology, Edema psychology, Female, Humans, Middle Aged, Pain etiology, Pain pathology, Pain psychology, Pain Measurement, Pilot Projects, Pressure, Severity of Illness Index, Breast Cancer Lymphedema therapy, Breast Neoplasms psychology, Compression Bandages, Edema therapy, Pain prevention & control, Quality of Life psychology
- Abstract
Background: Lymphedema of the breast/chest wall after breast cancer treatment is often associated with pain and reduced quality of life. We conducted a pilot study to evaluate whether the use of a compression vest reduced symptoms of breast/chest wall edema in breast cancer patients. Methods and Results: This single-center study included patients ( n = 25) with symptomatic breast/chest wall edema with a pain score of ≥3 on the Numerical Rating Scales (range 1-10). The patients were instructed to wear a compression vest (Lymphatrex, Class II) for 6 months. Wilcoxon signed-rank tests were used to compare differences in patient-reported pain intensity/severity. Analyses included all patients with available data. In total, 17 (68%) continued to wear their vests for 6 months, whereas the other 8 withdrew prematurely. At baseline, median pain severity (4.9, interquartile range [IQR] 3.6-6.0) and pain interference (4.3, IQR 2.1-5.9) scores were significantly higher compared with pain scores after wearing the compression vest for 6 months (1.8 IQR 1.0-4.8 and 1.4 IQR 0.9-4.4, resp.). Patient-reported breast/chest wall swelling decreased from 92% ( n = 22) at baseline to 71% ( n = 12) at 6 months. The prevalence of moderate/severe patient-reported breast/chest wall pain declined from 63% ( n = 15) at baseline to 18% ( n = 3) at 6 months. Physical, emotional, and social functioning improved over time and was comparable to scores of the Dutch reference population. Conclusion: The results of this pilot study suggest that a compression vest could be an acceptable and effective treatment option for patients with painful breast/chest wall edema. In compliant patients, swelling and pain was significantly reduced.
- Published
- 2020
- Full Text
- View/download PDF
11. The Trials within Cohorts design faced methodological advantages and disadvantages in the exercise oncology setting.
- Author
-
Gal R, Monninkhof EM, van Gils CH, Groenwold RHH, van den Bongard DHJG, Peeters PHM, Verkooijen HM, and May AM
- Subjects
- Adult, Aged, Aged, 80 and over, Cohort Studies, Female, Humans, Middle Aged, Prospective Studies, Research Design, Biomedical Research methods, Breast Neoplasms therapy, Exercise Therapy methods, Patient Dropouts statistics & numerical data, Patient Participation statistics & numerical data, Patient Selection, Randomized Controlled Trials as Topic statistics & numerical data
- Abstract
Objectives: The Trials within Cohorts (TwiCs) design is an alternative for pragmatic randomized controlled trials (RCTs) and might overcome disadvantages such as difficult recruitment, dropout after randomization to control, and contamination. We investigated the applicability of the TwiCs design in an exercise oncology study regarding the recruitment process, representativeness of the study sample, contamination, participation, and dropout., Methods: The Utrecht cohort for Multiple BREast cancer intervention studies and Long-term evaLuAtion (UMBRELLA) Fit TwiCs evaluates an exercise intervention in inactive breast cancer patients. Eligible patients participating in the prospective UMBRELLA were identified and randomized. Patients randomized to the intervention (n = 130) were offered the intervention, whereas controls (n = 130) were not informed., Results: Fifty-two percent (n = 68) accepted the intervention. Because this rate was lower than expected, a larger sample size was required than initially estimated (n = 166). However, recruitment of 260 patients was still completed by one researcher within 30 months. Unselective eligibility screening and randomization before invitation improved representativeness. Disadvantage of the design might be inclusion of ineligible patients when cohort information is limited. Furthermore, the design faced higher noncompliance in the intervention group, but prevention of contamination., Conclusion: The TwiCs design improved logistics in recruitment and prevented contamination, but noncompliance due to refusal of the intervention was higher compared with conventional pragmatic exercise oncology RCTs, which may dilute the estimated intervention effect., (Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
12. Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer.
- Author
-
Charaghvandi RK, Yoo S, van Asselen B, Rodrigues A, van den Bongard DHJG, and Horton JK
- Abstract
Background: Following breast-conserving surgery and post-operative 3D-conformal accelerated partial breast irradiation (APBI), suboptimal cosmetic results have been reported. Preoperative radiation delivery to the intact tumor enables better target visualization and treatment volume reduction. Single dose preoperative APBI has the potential to improve toxicity profiles, reduce treatment burden and enable in vivo exploration of breast cancer radiogenomics., Purpose: Develop practical guidelines for single dose external beam preoperative APBI., Methods: Recommended dose constraints were derived from pooled dosimetry estimates from 2 clinical trials. In an American dose escalation trial, a uniform 15, 18 or 21 Gy dose has previously been evaluated for non-lobular cT1N0 or low/intermediate grade DCIS <2 cm in prone position ( n = 32). In the Netherlands, the feasibility of ablative APBI (20 Gy to GTV, 15 Gy to CTV) to non-lobular cT1N0 in supine position, is currently being explored ( n = 15). The dosimetric adherence to the developed constraints was evaluated in new APBI plans with a 21 Gy uniform dose but an extended CTV margin ( n = 32)., Results: Dosimetric data pooling enabled the development of practical guidelines for single dose preoperative APBI., Conclusion: The developed guidelines will allow further explorations in the promising field of single dose preoperative external beam APBI for breast cancer treatment.
- Published
- 2017
- Full Text
- View/download PDF
13. Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer.
- Author
-
Knuttel FM, van den Bosch MA, Young-Afat DA, Emaus MJ, van den Bongard DH, Witkamp AJ, and Verkooijen HM
- Subjects
- Aged, Female, Humans, Mammaplasty, Middle Aged, Neoplasm Staging, Netherlands, Visual Analog Scale, Breast Neoplasms psychology, Breast Neoplasms therapy, Mastectomy psychology, Minimally Invasive Surgical Procedures psychology, Patient Preference
- Abstract
Background: Noninvasive or minimally invasive treatments are being developed as alternatives to surgery for patients with early-stage breast cancer. Patients' preferences with regard to these new treatments have not been investigated., Objectives: To assess preferences of patients with breast cancer and of healthy women regarding these new techniques, compared with conventional surgical treatments., Methods: Six hypothetical breast cancer treatment-outcome scenarios were developed: three standard surgical scenarios (mastectomy, mastectomy with immediate implant-based reconstruction, and breast-conserving therapy [BCT]) and three minimally invasive or noninvasive scenarios (radiofrequency ablation, magnetic resonance-guided high-intensity focused ultrasound ablation, and single-dose ablative radiotherapy). Participants rated treatment-outcome scenarios by visual analogue scale (VAS) and time trade-off (TTO). The Friedman and post hoc Wilcoxon signed-rank tests were used to test whether scores were significantly different from BCT., Results: Seventy-one patients with breast cancer and 50 healthy volunteers participated. Overall, BCT was rated the highest in terms of VAS (0.80) and TTO (0.90) scores. After stratification, BCT ranked the highest in most subgroups, with the exception of healthy individuals, who had given the highest score to ablative boost (VAS, 0.80; TTO, 0.88). Mastectomy with immediate reconstruction was the least preferred in most subgroups., Conclusions: This study showed no significant preference for minimally invasive treatment for breast cancer. Using hypothetical scenarios, breast cancer survivors attributed the highest scores to BCT, whereas healthy volunteers showed a slight preference for minimally invasive treatments., (Copyright © 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
14. MRI-guided single fraction ablative radiotherapy for early-stage breast cancer: a brachytherapy versus volumetric modulated arc therapy dosimetry study.
- Author
-
Charaghvandi RK, den Hartogh MD, van Ommen AM, de Vries WJ, Scholten V, Moerland MA, Philippens ME, Schokker RI, van Vulpen M, van Asselen B, and van den Bongard DH
- Subjects
- Aged, Breast Neoplasms pathology, Female, Humans, Middle Aged, Neoplasm Staging, Organs at Risk, Radiotherapy Planning, Computer-Assisted methods, Brachytherapy, Breast Neoplasms radiotherapy, Magnetic Resonance Imaging methods, Radiotherapy, Image-Guided methods, Radiotherapy, Intensity-Modulated methods
- Abstract
Background and Purpose: A radiosurgical treatment approach for early-stage breast cancer has the potential to minimize the patient's treatment burden. The dosimetric feasibility for single fraction ablative radiotherapy was evaluated by comparing volumetric modulated arc therapy (VMAT) with an interstitial multicatheter brachytherapy (IMB) approach., Methods and Materials: The tumors of 20 patients with early-stage breast cancer were delineated on a preoperative contrast-enhanced planning CT-scan, co-registered with a contrast-enhanced magnetic resonance imaging (MRI), both in radiotherapy supine position. A dose of 15 Gy was prescribed to the planned target volume of the clinical target volume (PTVCTV), and 20 Gy integrated boost to the PTV of the gross tumor volume (PTVGTV). Treatment plans for IMB and VMAT were optimized for adequate target volume coverage and minimal organs at risk (OAR) dose., Results: The median PTVGTV/CTV receiving at least 95% of the prescribed dose was ⩾99% with both techniques. The median PTVCTV unintentionally receiving 95% of the prescribed PTVGTV dose was 65.4% and 4.3% with IMB and VMAT, respectively. OAR doses were comparable with both techniques., Conclusion: MRI-guided single fraction radiotherapy with an integrated ablative boost to the GTV is dosimetrically feasible with both techniques. We perceive IMB less suitable for clinical implementation due to PTVCTV overdosage. Future studies have to confirm the clinical feasibility of the single fraction ablative approach., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
15. Post-lumpectomy CT-guided tumor bed delineation for breast boost and partial breast irradiation: Can additional pre- and postoperative imaging reduce interobserver variability?
- Author
-
DEN Hartogh MD, Philippens ME, VAN Dam IE, Kleynen CE, Tersteeg RJ, Kotte AN, VAN Vulpen M, VAN Asselen B, and VAN DEN Bongard DH
- Abstract
For breast boost radiotherapy or accelerated partial breast irradiation, the tumor bed (TB) is delineated by the radiation oncologist on a planning computed tomography (CT) scan. The aim of the present study was to investigate whether the interobserver variability (IOV) of the TB delineation is reduced by providing the radiation oncologist with additional magnetic resonance imaging (MRI) or CT scans. A total of 14 T1-T2 breast cancer patients underwent a standard planning CT in the supine treatment position following lumpectomy, as well as additional pre- and postoperative imaging in the same position. Post-lumpectomy TBs were independently delineated by four breast radiation oncologists on standard postoperative CT and on CT registered to an additional imaging modality. The additional imaging modalities used were postoperative MRI, preoperative contrast-enhanced (CE)-CT and preoperative CE-MRI. A cavity visualization score (CVS) was assigned to each standard postoperative CT by each observer. In addition, the conformity index (CI), volume and distance between centers of mass (dCOM) of the TB delineations were calculated. On CT, the median CI was 0.57, with a median volume of 22 cm
3 and dCOM of 5.1 mm. The addition of postoperative MRI increased the median TB volume significantly to 28 cm3 (P<0.001), while the CI (P=0.176) and dCOM (P=0.110) were not affected. The addition of preoperative CT or MRI increased the TB volume to 26 and 25 cm3 , respectively (both P<0.001), while the CI increased to 0.58 and 0.59 (both P<0.001) and the dCOM decreased to 4.7 mm (P=0.004) and 4.6 mm (P=0.001), respectively. In patients with CVS≤3, the median CI was 0.40 on CT, which was significantly increased by all additional imaging modalities, up to 0.52, and was accompanied by a median volume increase up to 6 cm3 . In conclusion, the addition of postoperative MRI, preoperative CE-CT or preoperative CE-MRI did not result in a considerable reduction in the IOV in postoperative CT-guided TB delineation, while target volumes marginally increased. The value of additional imaging may be dependent on CVS.- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.